#CDC

Reports that Ebola-exposed and infected Americans were sent to Germany and Prague instead of the United States have sharpened concerns about evacuation policy during a fast-moving outbreak in Congo.

A revised charter for the CDC’s vaccine advisory committee has been withdrawn after an administrative error, halting changes that critics said would have widened the path for anti-vaccine influence over federal policy.

A CDC analysis identified 50 large tuberculosis outbreaks from 2017 to 2023, with many cases linked to U.S.-born populations and elevated rates of substance use, homelessness and incarceration.

A new Lancet analysis says the United States has already missed four of the CDC’s seven measles-elimination indicators, with the others increasingly at risk after outbreaks spread to 45 states.

A newly published charter for the CDC’s vaccine advisory panel adds an explicit focus on vaccine safety after a judge suspended most Trump administration appointments to the committee.

A new study highlighted by Medical Xpress says HIV infections could rise 10% if U.S. CDC funding for local testing programs ends, underscoring how closely diagnosis, treatment, and prevention remain linked.

Health Secretary Robert F. Kennedy Jr. has renewed and revised the charter for the CDC’s vaccine advisory committee in a way that appears to broaden his authority over who can serve on the panel.

With nearly 1,000 confirmed measles cases in 2026 spread across close to half of U.S. states, public health officials are sounding the alarm about a broader crisis. Declining vaccination rates could open the door to resurgences of mumps, hepatitis B, and other diseases once thought conquered.

The CDC has had a Senate-confirmed director for just 28 days during the current administration, even as Congress passes its first bipartisan health care legislation in over three years. A look at the leadership vacuum, policy progress, and regulatory flashpoints shaping Washington health policy.

The World Health Organization has called a CDC-funded $1.6 million trial in Guinea-Bissau unethical, saying it would withhold a proven life-saving vaccine from newborns in a country where 1 in 5 people carry hepatitis B.